The path to implementation of personalized medicine of aromatase inhibitors in patients with breast cancer

被引：0
作者：
Liu, Xiaoman [1 ]
Beith, Jane [2 ]
Low, Siew-Kee [1 ]
Boddy, Alan V. [1 ]
机构：
[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[2] Chris OBrien Lifehouse Ctr, Sydney, NSW 2006, Australia
来源：
PHARMACOGENOMICS | 2016年 / 17卷 / 17期
关键词：
aromatase inhibitors; clinical implementation; molecular profiling; personalized medicine; pharmacogenomics; ENDOCRINE THERAPY; PREDICTION; RESISTANCE; METHYLATION; TAMOXIFEN; WOMEN;
D O I：
10.2217/pgs-2016-0141
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1861 / 1864
页数：4
相关论文
共 21 条
  • [1] 21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients
    Akashi-Tanaka, Sadako
    Shimizu, Chikako
    Ando, Masashi
    Shibata, Tatsuhiro
    Katsumata, Noriyuki
    Kouno, Tsutomu
    Terada, Kotoe
    Shien, Tadahiko
    Yoshida, Miwa
    Hojo, Takashi
    Kinoshita, Takayuki
    Fujiwara, Yasuhiro
    Yoshimura, Kenichi
    [J]. BREAST, 2009, 18 (03) : 171 - 174
  • [2] Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
    Davies, C.
    Godwin, J.
    Gray, R.
    Clarke, M.
    Darby, S.
    McGale, P.
    Wang, Y. C.
    Peto, R.
    Pan, H. C.
    Cutter, D.
    Taylor, C.
    Ingle, J.
    [J]. LANCET, 2011, 378 (9793) : 771 - 784
  • [3] Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age
    Desta, Z.
    Kreutz, Y.
    Nguyen, A. T.
    Li, L.
    Skaar, T.
    Kamdem, L. K.
    Henry, N. L.
    Hayes, D. F.
    Storniolo, A. M.
    Stearns, V.
    Hoffmann, E.
    Tyndale, R. F.
    Flockhart, D. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (05) : 693 - 700
  • [4] Liquid Biopsies: Genotyping Circulating Tumor DNA
    Diaz, Luis A.
    Bardelli, Alberto
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (06) : 579 - +
  • [5] Mechanisms of resistance to aromatase inhibitors
    Dowsett, M
    Martin, LA
    Smith, I
    Johnston, S
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 95 (1-5) : 167 - 172
  • [6] Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
    Dowsett, Mitch
    Cuzick, Jack
    Wale, Christopher
    Forbes, John
    Mallon, Elizabeth A.
    Salter, Janine
    Quinn, Emma
    Dunbier, Anita
    Baum, Michael
    Buzdar, Aman
    Howell, Anthony
    Bugarini, Roberto
    Baehner, Frederick L.
    Shak, Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1829 - 1834
  • [7] Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
    Ellis, Matthew J.
    Tao, Yu
    Luo, Jingqin
    A'Hern, Roger
    Evans, Dean B.
    Bhatnagar, Ajay S.
    Ross, Hilary A. Chaudri
    von Kameke, Alexander
    Miller, William R.
    Smith, Ian
    Eiermann, Wolfgang
    Dowsett, Mitch
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (19) : 1380 - 1388
  • [8] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Dikshit, Rajesh
    Eser, Sultan
    Mathers, Colin
    Rebelo, Marise
    Parkin, Donald Maxwell
    Forman, David
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : E359 - E386
  • [9] Gotay C, 2011, EXPERT REV PHARM OUT, V11, DOI [10.1586/ERP.11.80, 10.1586/erp.11.80]
  • [10] Specific site methylation in the 5′-flanking region of CYP1A2 -: Interindividual differences in human livers
    Hammons, GJ
    Yan-Sanders, Y
    Jin, B
    Blann, E
    Kadlubar, FF
    Lyn-Cook, BD
    [J]. LIFE SCIENCES, 2001, 69 (07) : 839 - 845
123